Home/Filings/4/0001140361-15-005641
4//SEC Filing

Raptor Pharmaceutical Corp 4

Accession 0001140361-15-005641

CIK 0001070698operating

Filed

Feb 10, 7:00 PM ET

Accepted

Feb 11, 8:12 PM ET

Size

7.3 KB

Accession

0001140361-15-005641

Insider Transaction Report

Form 4
Period: 2015-02-09
Happel David
Chief Commerical Officer
Transactions
  • Award

    Common Stock

    2015-02-09+5,2295,229 total
  • Award

    Stock options (right to buy)

    2015-02-09+19,58319,583 total
    Exercise: $9.36Exp: 2025-02-09Common Stock (19,583 underlying)
Footnotes (2)
  • [F1]Restricted Stock Units ("RSUs"). The Reporting Person is entitled to one (1) share of common stock for each one (1) RSU upon the vesting thereof.
  • [F2]Stock options vest 6/48ths on the six month anniversary of grant date and 1/48th per month thereafter.

Documents

1 file

Issuer

Raptor Pharmaceutical Corp

CIK 0001070698

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001070698

Filing Metadata

Form type
4
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 8:12 PM ET
Size
7.3 KB